SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharma reports 10% rise in Q3 consolidated net profit

29 Jan 2015 Evaluate

Torrent Pharmaceuticals has reported results for third quarter ended December 31, 2014.

The company has registered 9.65% fall in its net profit at Rs 103.00 crore for the quarter under review as compared to Rs 114.00 crore for the same quarter in the previous year. However, total income of the company has increased 18.17% at Rs 878.00 crore for Q3FY15 as compared Rs 743.00 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit rose 5.70% to Rs 167.00 crore for the Q3 FY15 as compared to Rs 158.00 crore in Q3 FY14. Moreover, the total income increased 20.29% to Rs 1233.00 crore in the quarter under review as compared to Rs 1025.00 crore in the corresponding quarter previous year.

Torrent Pharma Share Price

4351.60 -5.90 (-0.14%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.30
Dr. Reddys Lab 1307.00
Cipla 1361.00
Zydus Lifesciences 940.10
Lupin 2460.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×